Our Lasted Insights
Are You Giving Away Control of Your Product in Vietnam?
January 5, 2026
Are You Giving Away Control of Your Product in Vietnam? Many manufacturers let distributors hold their Market Authorization (MA) /license. While convenient, this can limit your control, flexibility, and long-term strategy. Strategic Separation = Market PowerBy appointing an independent third-party MAH (like Medflash), you keep regulatory ownership separate from sales. This unlocks: 1. Market Access
VIETNAM: The Medical Tourism Plan is a MedTech Investment
December 15, 2025
VIETNAM: The Medical Tourism Plan is a MedTech Investment Vietnam is strategically moving to put medical tourism on the map via a new Ministry of Health plan (2025–2030). This isn’t just a service push—it’s the clearest policy signal for accelerated medical device sector growth you can get. Why Global MD Firms Must Look at Vietnam
Three strategic pathways to navigate Vietnam’s Medical Device Market
December 15, 2025
Three strategic pathways to navigate Vietnam’s Medical Device Market Vietnam’s medical device market is booming—expected to reach nearly US$2.5 billion by 2030, with 90–95% of equipment imported. As the MoH tightens regulations under Decree 98/2021 and its amendments, the path to market access is more structured than ever. 1. Establish a Legal Entity (Subsidiary, Representative
EuroCham Vietnam’s Whitebook 2025: A Roadmap for Sustainable Growth Amid Global Challenges
December 14, 2025
EuroCham Vietnam’s Whitebook 2025: A Roadmap for Sustainable Growth Amid Global Challenges EuroCham’s 2025 Whitebook focuses on: Strengthening EU-Vietnam Ties: As the EU-Vietnam Free Trade Agreement (EVFTA) nears its fifth anniversary, the Whitebook underscores its impact—EU-Vietnam trade grew 16% in 2024, surpassing $68 billion. EuroCham Chairman Bruno Jaspaert highlighted Vietnam’s “bamboo diplomacy” as key to
Navigating Borderline Medical Devices: Global Regulatory Insights
December 13, 2025
Navigating Borderline Medical Devices: Global Regulatory Insights Borderline medical devices—products that blur the lines between medical devices, medicinal products, cosmetics, or other categories—pose unique challenges for manufacturers and regulators. Regulatory authorities worldwide provide guidance, manuals, and case studies to clarify classifications, helping ensure compliance and market access. Below, we summarize key resources from major regions